GR1802

GR1802 · Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for GR1802, covering 2023-08-29 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps [Phase 3]